Addison Group
Addison Group logo, various greens, blue, and white pinwheel

Addison Group, a national leader in professional services specializing in talent solutions and consulting, announces today that it has fully incorporated Beacon Resources, an Addison Group company, to move forward under the Addison Group brand name.

For current clients of Beacon Resources, its brand integration to Addison Group includes access to a robust network of talent with significantly greater reach and opportunities to secure highly qualified professionals. Beacon Resources' clients will also gain access to the full portfolio of Addison's recruiting capabilities beyond finance and accounting, including information technology, non-clinical healthcare, human resources, administration, and digital marketing.

In 2014, Beacon Resources, headquartered in Woodland Hills, California, was acquired by DLC group to make the larger more established finance and accounting professional services firm an ideal acquisition. Addison Group, seeking to expand its West Coast presence and grow its market share, acquired the group in 2019. Throughout the past decade via strategic partnerships and alignments, Addison Group has blended a multitude of relationship-based staffing and consulting firms into what is now a major market contender, and viable award-winning professional services consortium. 

Beacon Resources' Managing Directors and team retain their roles within the expanded organization:

"The entire Beacon Resources team is excited about the tremendous opportunities it gives to our clients. Our team remains committed to facilitating ideal connections between our clients and our candidates, and now formally as Addison Group, our recruiting experts will have access to even more resources to perform exceptional services on a larger scale." ~ Odeh Haddad, Managing Director, Beacon Resources

"Our transition to Addison Group has been completely synergistic because our motto and our methodology are aligned with our passion for people. While the Beacon Resources brand has officially retired, our commitment to building and maintaining meaningful relationships has only been strengthened with the increased reach and additional resources of Addison Group. Completely integrating with Addison will allow us to nurture existing connections and expand offerings into newly emerging markets." ~ Dana Carr Brown, Managing Director, Beacon Resources

Under the integration, the Beacon Resources brand will officially retire. All of its existing business relationships and activities continue under the Addison Group name while providing the same unparalleled level of service.

About Addison Group

Addison Group, a leading talent solutions and consulting company, provides expertise with a national reach and a localized touch. Addison offers a full suite of consulting and recruiting capabilities across multiple sectors, including information technology, finance and accounting, non-clinical healthcare, human resources, administrative, and digital marketing. Addison has been repeatedly recognized by the media as one of the fastest-growing private companies in the United States by Forbes' Top 200 America's Best Professional and Specialist Search Firms, America's Best Recruiters and Executive Search Firms, and America's Best Temporary Staffing Firms, SIA Top 100 Staffing Bold Leaders, and Inc. Best 100 Places to Work. Known for its people-first culture, Addison combines deep expertise, client and candidate relationships, and a growing network of offices across the U.S. to provide national reach with a localized touch.

Cedar, an enterprise healthcare engagement platform that improves the end-to-end consumer financial journey, was recently endorsed by the Montana Hospital Association's shared services division MHA Ventures (MHAV) as their preferred choice in patient financial engagement technology. Through this endorsement, Cedar will be listed as the MHAV's only preferred patient financial engagement technology.

The MHAV is a hospital member organization that nominates vendors through a rigorous and lengthy vetting process, identifying relevant technologies for their hospital members in the region. The association collects organizational background, testimonials, references, offerings and other essential company details. 

Cedar was selected based on its ability to drive results in a time when health systems face significant financial pressures. Cedar's flagship solution, Cedar Pay, generates an average 30% lift in patient payments for clients, with 89% of patients reporting an exceptional financial experience.  

"MHA is excited to launch a partnership with Cedar. This proven, impactful patient engagement solution is making a big difference for a rural state like Montana. In fact, several MHA members are already seeing positive results. Cedar is a great solution that simplifies the patient experience, saves employee time and improves cash flow," said Rebecca Schauf, Sales & Marketing Manager, MHA Ventures.

Cedar is excited about the MHAV partnership and looks forward to improving financial outcomes for both patients and providers in Montana. 

"We commend the Montana Hospital Association for its commitment to improving the patient financial experience, particularly in light of the challenging economic times that both patients and health systems are facing," said Florian Otto, CEO and Co-founder of Cedar. "We look forward to bringing the same consumer-centric approach to financial engagement to Montanans that we've delivered for health systems across the country."

Cedar is on a mission to empower individuals to easily and affordably pursue the care they need, transforming the patient financial experience through a unique end-to-end solution. To learn more about Cedar's innovative platform, visit https://www.cedar.com/.

About Cedar

Cedar is committed to improving the healthcare billing experience for all. With an innovative platform that connects providers and payers, Cedar empowers healthcare consumers with a personalized journey—all powered by data science and interactive design. For Cedar clients, this leads to improved financial outcomes, more efficient operations and greater consumer loyalty. To learn more about why leading U.S. healthcare organizations trust Cedar to manage the end-to-end financial experience from pre-registration to post-visit billing, visit www.cedar.com and join us on LinkedIn, Twitter, Facebook and YouTube.

About Montana Hospital Association

The Montana Hospital Association is a nonprofit organization with more than 80 members, including 100% of Montana's hospitals, that provide the full spectrum of healthcare services. This includes hospital inpatient and outpatient services, skilled nursing facilities, home health, hospice, physician services, assisted living, senior housing, and insurance services. MHA Ventures, Inc. is the for-profit subsidiary of MHA, created to deliver solutions that improve patient care, reduce operating costs and strengthen the financial viability of Montana's hospitals. Learn more at MTHA.org.

Everwell Health

Everwell Health is excited to announce two executive leaders that have recently joined the organization which further strengthens the company's innovation capabilities and supports its long-term growth strategy.  Volkan Eren has assumed the newly created role of Vice President, Sales & Business Development, while Catherine Kwik-Uribe will serve as Vice President of Scientific & Regulatory Affairs. 

Mr. Eren will head the sales team and lead commercial strategy and sales administration. Volkan joins the organization from a unique background with fast-paced entrepreneurial businesses like Enzymotec, along with experience and roles of increased responsibility leading sales teams at larger scaled companies like Frutarom and IFF.  Volkan's prior role at IFF was Sales Leader for Supplements, Food, & Beverages.  Volkan will focus on business expansion and diversification, as well as leading our sales organization. Volkan holds a bachelor's degree in Business Administration & Management from Fairleigh Dickinson University and earned a master's degree in Economics from City University of New York.

Dr. Kwik-Uribe is responsible for maintaining the excellent reputation that Nutrition21 (Everwell Health's first platform investment) has earned throughout the years, while creating new strategies to build expertise, ideas, and processes that support the platform's "science-first" approach.  Catherine comes from a successful career at Mars Incorporated, her most recent role as VP, Scientific & Regulatory Affairs, Applied Science & Nutrition for Mars Edge.  Catherine has worked across multiple product categories and led scientific teams of all sizes, conducted extensive research in human health and nutrition, and led the translation of science into consumer-relevant claims.  Her expertise will drive the company's clinical research needs and support new product claims and regulatory approvals in the U.S and international markets.  Dr. Kwik-Uribe earned her Ph.D. in Human Nutrition from University of California, Davis and completed her post-doctoral training in toxicology at the University of California, Santa Cruz. Catherine has authored and co-authored more than 40 publications on the analysis, safety, and efficacy of nutrients and bioactive constituents in foods.

Both executives also bring M&A experience that will be important as Everwell Health invests to expand the platform.  Steve Rosenman, CEO of Everwell Health commented, "These new leaders compliment our existing team at Nutrition21.  Their experience and success, both at nimble, high growth companies and at highly professional, scaled global enterprises will support Everwell Health's dual growth strategy of optimizing organic opportunities at Nutrition21, while aggressively developing strategic partnerships and pursuing external business development.  These roles align with our commitments and continued investments in science, and in capabilities to serve our customers and help them grow." 

ABOUT EVERWELL HEALTH

Everwell Health aims to help people look, feel and perform their best by advancing the science of safe, convenient and attainable functional ingredients. The company adds meaningful value to dietary supplement, food and beverage brands by offering scientifically substantiated functional ingredient solutions. The company is actively focused on business development partnerships across the functional ingredients market. www.everwellhealth.com

ABOUT NUTRITION21

Nutrition21 is an industry-leading developer and marketer of efficacious, high-value, clinically substantiated ingredients for use in dietary supplements, functional foods and beverages. With decades of experience, the Company's scientific platform has continued to create unique, patented products that are both safe and clinically effective. To build consumer trust, Nutrition21 ensures product efficacy and safety through a product development process that involves rigorous preclinical and clinical research. The Company currently holds over 100 domestic and international issued and pending patents for its ingredients which support unique claims associated with sports nutrition, weight management, cognitive health, and beauty-from-within, among others. For more information on Nutrition21 visit: www.nutrition21.com

Blue Sky Specialty Pharmacy, a leading innovator in the Specialty Pharmacy space, announced recently that they have just received the coveted URAC designation status pursuant to Rare Disease - Center of Excellence, Accreditation.

URAC is the independent leader in promoting health care quality by setting high standards for clinical practice, consumer protections, performance measurement, operations infrastructure, and risk management. By achieving this status, Blue Sky Specialty Pharmacy demonstrates commitment to quality care, enhanced processes, patient safety, and improved outcomes.

"The Rare URAC designation clearly demonstrates our ability to meet rigorous regulatory requirements and National standards. It is the benchmark for the quality of an organization and care they can provide patients with rare diseases. It is an exciting achievement for our team, and we look forward to helping more patients along their healthcare journey," says Blue Sky Founder and CEO Curt Nesbitt. 

"Pharmacies and related pharmaceutical services play a critical role in the health care delivery system now more than ever. Given the complicated nature of chronic disease, pharmacies like Blue Sky Specialty Pharmacy do much more than simply fill a prescription. As trusted experts at the frontline of care delivery, they often provide targeted patient support and education to ensure proper medication management," said URAC President and CEO Shawn Griffin, M.D.

To learn more about Blue Sky Specialty Pharmacy, visit blueskyspecialtypharmacy.com.

About Blue Sky Specialty Pharmacy

With locations in Mount Pleasant, SC, Daphne AL, and Charlotte, NC, Blue Sky Specialty Pharmacy was founded with the vision to re-imagine pharmacy as we know it. Our goal is to create meaningful and enduring impact on our practices and patients and to alleviate the administrative burden and headaches associated with specialty treatments so our practices and providers can focus on treating patients.

About URAC

Founded in 1990 as a non-profit organization, URAC is the independent leader in promoting health care quality and patient safety through renowned accreditation programs. URAC develops it's evidence-based standards in collaboration with a wide array of stakeholders and industry experts. The company's portfolio of accreditation and certification programs span the health care industry, addressing health care management and operations, pharmacies, tele-health, health plans, medical practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.

Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces the interim results for its Diabetic Foot Ulcer ("DFU") Clinical Study, initiated in June 2022. The DeepView® Wound Imaging System diagnostic accuracy calculated in the interim analysis, being the prediction of a 50% DFU size reduction by week four, has improved five-percentage points to 86% on day one. This increase in diagnostic accuracy will strengthen the Company's planned 2023 FDA submission for its DeepView® DFU indication.

The four-week milestone in DFU reduction in the clinical treatment pathway for a DFU patient is meaningful to determine if alternative treatment is needed. The interim analysis was performed with an initial 100 U.S. adult subjects out of the targeted 200 subjects enrolled and showed: 

• 86% diagnostic accuracy, from the previously reported 81%
• 89% sensitivity 
• 83% specificity

Currently, there are no diagnostic tools available in DFU healing prediction. The standard of care for DFU relies on physicians using a wait-and-see approach of up to 30 days to determine if there is a need for advanced intervention.

The DFU study is currently running at five clinical sites in the U.S.  As the Company's regulatory strategy evolves, it is adding additional clinical sites, three contracted, to ensure study completion in 1H 2023. The Company plans to announce additional EU/UK DFU clinical studies in the near future and will provide updates accordingly. The Company remains on track to complete its FDA 2023 regulatory submission. 

Niko Pagoulatos, Chief Operating Officer of Spectral MD, said: "We are encouraged by the interim observations from the DFU Clinical Study, and we look forward to completing enrollment to finalize DeepView® DFU indication performance analysis and to submit for regulatory approvals. The results from the interim analysis further validate how the DeepView® technology could significantly help transform the lives of people suffering from Diabetic Foot Ulcers." 

Dr. Brock Liden, Podiatry Wound Specialist at Wound and Feet Liden and Principal Investigator in the DFU Clinical Study, commented: "These are extremely encouraging results that show the incredible potential of DeepView® to significantly transform how we treat, manage, and assess Diabetic Foot Ulcers. Diabetic Foot Ulcers are unusually challenging due to the many comorbidities associated with diabetes, which may interrupt the healing process. I look forward to the continued collaboration with Spectral MD as we work to collect meaningful data to further validate this transformative technology."

Burn Indication Update:

The Company has been working on the BARDA funding contract for the Burn indication, and the recent US $ 8.2 million contract expansion with BARDA continues to support interoperability features and commercial readiness for the DeepView® Wound Imaging System. The updates for the current DeepView® Burn AI Training Study are:

• Since year end 31 Dec. 2022, adult enrollment is complete.
• The study population covers demographic and geographic variability.
• The study is currently performed at 11 world-renowned research hospitals, with additional pediatric research sites established.
• Study is expected to be completed 1H 2023.

Spectral MD is in constant communication with BARDA to further develop its infrastructure readiness for a federal-level commercial contract. 

About Spectral MD:                                                                                   

We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown" ® with our DeepView^® Wound Imaging System.

www.spectralmd.com

[email protected] 

Robert White
Robert White, IDLife's new Chief Financial Officer

IDLife, LLC CEO Josh Paine has appointed Robert White as the new Chief Financial Officer, and Justin Sparks will transition to the company's Chief Financial Analyst. 

"A company's ability to grow vertically is determined by its willingness to invest in its foundations and leadership. We are thrilled to welcome Robert White to our IDLife family. His proven leadership, relationships and core values make him the perfect fit for where we are headed as a company. Additionally, allowing Justin Sparks to focus on financial modeling, predictive analytics and machine learning allows IDLife to better serve our growing base of Associates and Customers and give them the information and tools that they need to excel in this rapidly changing marketplace," said Paine. 

As Chief Financial Officer, White will lead the company's financial activities including accounting, controllership, tax, treasury, investor relationships, and more. 

About Robert White

Robert White is a well-appointed Certified Public Accountant with over 30 years of experience. Before joining IDLife, White has held various professional accounting positions and has 10 years of experience in the social selling industry. "I couldn't be more excited to join the team at IDLife and support a legacy of great products and great people," said White. 

Forward Progress

IDLife founder and owner Logan Stout is proud of the decision to bring White to the team and believes this is just another sign of the exciting future ahead. "I'm proud of Josh and the team. It's incredible to have attracted this caliber of individuals working together to advance the company's mission. This addition just further brightens the company's future for growth, impact and momentum," said Stout. 

IDLife continues its massive growth plan in 2023. Paine's vision to create a connected, robust community of people committed to healthy living is moving full steam ahead. The Company is excited to help thousands more people do life better!